Positron emission tomography (PET) is now an important cancer imaging tool, both for
diagnosis and staging, as well as offering prognostic information based on response. This …

In the past 10 years, positron emission tomography (PET), usually with 18 F-fluoro-2-deoxy-
D-glucose (FDG), has become an important imaging modality in patients with lung cancer …

Background Positron emission tomography (PET) scanningis used increasingly to detect
and stage lung cancer, but the testperformance characteristics and relationship of PET to …

Since its introduction in 1974, positron emission tomography (PET) has gained widespread
use, especially in diagnosis and staging of lung cancer. In this respect, 18F …

BACKGROUND:: The evidence of clinical value of positron emission tomography (PET) with
fluorine-18 fluorodeoxyglucose (FDG) in lymph node (LN) staging in non-small cell lung …

Background We compared the diagnostic accuracy of integrated positron-emission
tomography (PET) and computed tomography (CT) with that of CT alone, that of PET alone …

Background Determining the stage of non–small-cell lung cancer often requires multiple
preoperative tests and invasive procedures. Whole-body positron-emission tomography …

Lung cancer is the leading cause of cancer-related death in industrialized countries. The
overall mortality rate for lung cancer is high, and early diagnosis provides the best chance …

Integrated positron emission tomography/computed tomography (PET/CT) has many
advantages over solitary PET and CT, which has led it to become an increasingly …

PURPOSE Solitary pulmonary nodules (SPNs) are commonly identified by chest
radiographs and computed tomography (CT). Biopsies are often performed to evaluate the …